Altis Labs
AI endpoint software that predicts drug efficacy in oncology trials using novel biomarkers or algorithm
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2024
- Rank in peer group#9 of 55
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 55 peers
Line = medianBiotech · Software
- Granted patents#9 · top 16%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 4- PendingPredicting Adverse Reaction To Medical Treatment By Applying Artificial Intelligence To Medical Image DataUSPTOApplication 18538775
- PendingPredicting Medical Outcome Via Artificial Intelligence For Use By A Randomization AlgorithmUSPTOApplication 18317640
- GrantedMethod And Apparatus Utilizing Image-based Modeling In HealthcareUSPTOUS 12,136,484
Show all 4 patent records
- Predicting Adverse Reaction To Medical Treatment By Applying Artificial Intelligence To Medical Image DataJun 19, 2025 · Application 18538775Pending
- Predicting Medical Outcome Via Artificial Intelligence For Use By A Randomization AlgorithmNov 21, 2024 · Application 18317640Pending
- Method And Apparatus Utilizing Image-based Modeling In HealthcareNov 5, 2024 · US 12,136,484Granted
- Method And Apparatus Utilizing Image-based Modeling In Clinical Trials And HealthcareMay 11, 2023 · Application 17520103Pending
Related companies, and why
- Judo BioSimilar federal contract value in Biotech · null in contracts
- Kinaset TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Korro BioSimilar federal contract value in Biotech · null in contracts
- Matchpoint TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Obsidian TherapeuticsSimilar federal contract value in Biotech · null in contracts
- SUNNYLIFE PHARMA INC.Similar federal contract value in Biotech · null in contracts
Press
Altis Labs AI Imaging Endpoint Predicts Overall Survival Benefit in Phase 3 Lung Cancer Trial: Data Presented at IASLC WCLC 2026Financial Post
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .